Effect of intravenous vitamin c in decreasing ferritin level in patients with ESRD under dialysis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191112045426N1

Enrollment

Registered

2020-01-07

Start date

2020-04-11

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease (CKD). Anemia in chronic kidney disease

Interventions

Intervention 1: Intervention group: The intervention group received intravenous ascorbic acid 500 mg three times a week after each dialysis session for 3 months with erythropoietin IV. Intervention 2:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing hemodialysis with iron deficiency anemia with Hb 500 ng / ml) and transferrin saturation (TSAT = 20%)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Age. Timepoint: before intervention. Method of measurement: Form.;Gender. Timepoint: before intervention. Method of measurement: Form.;Marital status. Timepoint: before intervention. Method of measurement: Form.;Serum ferritin level. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Hemoglobin. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;TIBC(Total Iron binding capacity ). Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Transferrin saturation. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Intervention group. Timepoint: before intervention and after three months. Method of measurement: software.	—

Measure

Time frame

Age. Timepoint: before intervention. Method of measurement: Form.;Gender. Timepoint: before intervention. Method of measurement: Form.;Marital status. Timepoint: before intervention. Method of measurement: Form.;Serum ferritin level. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Hemoglobin. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;TIBC(Total Iron binding capacity ). Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Transferrin saturation. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Intervention group. Timepoint: before intervention and after three months. Method of measurement: software.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Taheri

Qazvin University of Medical Sciences

m.t.a.h.e.r.i@yandex.com+98 28 3368 1570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026